| Document Date: 2014-12-01 05:17:36
Open Document File Size: 902,29 KBShare Result on Facebook
Company CDI / Ferring Pharmaceuticals SA / vWD / / Continent Europe / / Country Germany / Denmark / Canada / / Event FDA Phase / / IndustryTerm telephone followup / alarm+placebo / pharmacotherapeutic / pharmaceutical formulation / alarm+desmopressin / body systems / treatment groups / desmopressin products / / MedicalCondition von Willebrand’s disease / disease / mild/moderate haemophilia A. Table / mild haemophilia A / drug-induced thrombocyte dysfunction / contraction / cirrhosis / / Position CONTENTS I. Executive / EXECUTIVE / / Product MINIRIN / Desmopressin / dDAVP / OCTOSTIM injections / OCTOSTIM injection / OCTOSTIM / CS002 / Denmark / nasal / PNE-1-TBL / CS026/CL / 45A05-122 / /
SocialTag |
Art. 45 AR - CMDh_021_2009_Rev04_2014 04 - tracked